OKYO - OKYO Pharma Limited News

OKYO Pharma Says Chief Scientific Officer Raj Patil Purchases Of 3,363 Of Ordinary Shares On NASDAQ

OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing investigati

OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer

LONDON and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

LONDON and NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma Announces Purchase of Shares by Director

LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma Says CEO Robert Dempsey Purchases 15,000 Of Its Ordinary Shares On NASDAQ At $1.54 Per S

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Announces Purchase of Shares by Chief Executive Officer

LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma Announces Purchase of Shares by Chairman

LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma Says Gary Jacob, Chief Development Officer And Director, Increases His Holdings With Pur

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director

LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma Says Chief Medical Officer, Flavio Mantelli, Purchases 20,000 Of Its Ordinary Shares On

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer

LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma Says Chairman Gabriele Cerrone, Through Panetta Partners, Increases His Holdings With Pu

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Announces Purchase of Shares by Chairman

LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

Small caps: Replenish Nutrients, OKYO Pharma, EDM Resources

Market breadth continues to improve, even if it has pulled back lately, according to Adam Turnquist,

Disney streaming margins and parks business in focus ahead of earnings

Walt Disney Co (NYSE:DIS, XETRA:WDP) is scheduled to report fiscal third quarter results on August 5

OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans

OKYO Pharma Ltd (NASDAQ:OKYO) announced on Monday that it has filed its annual report on Form 20-F f

OKYO To Initiate Global Phase 3 NEPTUNE Trial In Neuropathic Eye Pain, Enrolling 111 Patients Across

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase

LONDON and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinica

OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans

OKYO Pharma Ltd (NASDAQ:OKYO) announced on Monday that it has filed its annual report on Form 20-F f

Delta Air Lines earnings resilience supports valuation, Bank of America says

Delta Air Lines Inc (NYSE:DAL) reaffirmed its full-year earnings outlook despite higher fuel costs,

US bank earnings could surprise to the upside as Bank of America highlights strong operating backdro

US banks could deliver broad earnings beats as strong capital markets activity, resilient economic c

First Hawaiian pushes into California with TriCo Bancshares deal

First Hawaiian, Inc. (NASDAQ:FHB) has agreed to acquire TriCo Bancshares (NASDAQ:TCBK), a combinatio

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and lowers

TSMC reports record June revenue, second quarter sales top guidance

Taiwan Semiconductor Manufacturing Co (ADR) (NYSE:TSM) reported record June revenue of NT$442.7 bill

OKYO Pharma advances toward Phase 3 FDA trial - ICYMI

OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week reported positive feedback from its Type D meeting w

OKYO Pharma advances toward Phase 3 FDA trial - ICYMI

OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week reported positive feedback from its Type D meeting w

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark

OKYO Pharma Announces Positive Feedback From FDA Type D Meeting, Validating Regulatory, Clinical Pat

FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway

12 Health Care Stocks Moving In Tuesday's After-Market Session

9 Health Care Stocks Moving In Wednesday's Pre-Market Session

OKYO Pharma's Panetta Partners Buys 10,119 Shares At An Average Price Of $1.59, Raising Executive Ch

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Director John Brancaccio Buys 5,000 Shares At An Average Price Of $1.61, Raising Total H

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Executive Buys More Shares, Signals Confidence

OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing investigati

OKYO Pharma Reports Trial Results For Eye Pain Treatment

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session